array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(25) "ROCHE DIAGNOSTICS LIMITED"
["slug"]=>
string(34) "ef866-gb-roche-diagnostics-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/5ce04174-8fff-4069-9bd1-2ef80ada854c"
["description"]=>
string(1583) "Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation"
["address_street"]=>
string(14) "Charles Avenue"
["address_place"]=>
string(12) "BURGESS HILL"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1956-09-14"
["website_domain"]=>
string(9) "roche.com"
["website_url"]=>
string(29) "https://diagnostics.roche.com"
["industry_codes"]=>
array(1) {
[0]=>
string(43) "Business Services, Not Elsewhere Classified"
}
["employee_count"]=>
int(658)
["article_count"]=>
int(3438)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(163) "Stock market ticker: Swiss stock exchange directionless before ECB interest rate decision - Analyst sees financial stocks 16 percent higher - Six new price targets"
["snippet_en"]=>
string(58) "The Swiss stock market was holding up on Thursday morning."
["url"]=>
string(182) "https://www.cash.ch/news/top-news/borsen-ticker-smi-vorborslich-hoher-givaudan-und-vat-im-mittelpunkt-inflationsdaten-vergraulen-anleger-an-der-wall-street-zwei-neue-kursziele-701298"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f5e8205d-9bf4-450d-ac68-118781d49f39"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2024-04-11"
["categories"]=>
array(5) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Going Public"
[2]=>
string(18) "General Investment"
[3]=>
string(12) "Stock Market"
[4]=>
string(24) "Stock Research & Ratings"
}
}
[1]=>
array(7) {
["title_en"]=>
string(152) "Stock market ticker: Swiss stock exchange starts new week with attempted recovery - Further losses for Roche - Analyst sees SMI shares 15 percent higher"
["snippet_en"]=>
string(106) "The Swiss stock exchange started the new trading week on Monday with a countermovement to Friday's losses."
["url"]=>
string(181) "https://www.cash.ch/news/top-news/borsen-ticker-schweizer-borse-startet-mit-erholungsversuch-in-neue-woche-weitere-verluste-fur-roche-analyst-sieht-smi-titel-15-prozent-hoher-700028"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1e1aab8e-1d54-401a-9918-c14a4cb84478"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2024-04-08"
["categories"]=>
array(4) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(12) "Going Public"
[3]=>
string(15) "Market Movement"
}
}
[2]=>
array(7) {
["title_en"]=>
string(171) "Stock market ticker: Swiss stock exchange with a negative trend - Temenos in focus in the evening - JPMorgan analyst sees Sika 11 percent lower - public holiday in the USA"
["snippet_en"]=>
string(122) "After the good performance of the previous week, the Swiss stock market started the new trading week cautiously on Monday."
["url"]=>
string(139) "https://www.cash.ch/news/top-news/borsen-ticker-smi-vorborslich-tiefer-durchzogene-us-vorgaben-vom-freitag-temenos-am-abend-im-fokus-684871"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7614b4ea-67ca-4a59-9a7a-f8735b4ed6c9"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2024-02-19"
["categories"]=>
array(12) {
[0]=>
string(20) "Corporate Governance"
[1]=>
string(15) "Market Movement"
[2]=>
string(18) "Ecological Impacts"
[3]=>
string(12) "Going Public"
[4]=>
string(18) "General Investment"
[5]=>
string(12) "Stock Market"
[6]=>
string(21) "Shareholders Feedback"
[7]=>
string(18) "Activist Investors"
[8]=>
string(24) "Stock Research & Ratings"
[9]=>
string(6) "Merger"
[10]=>
string(24) "Quarterly/Annual Figures"
[11]=>
string(11) "Acquisition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(87) "Stock market ticker: Swiss investors take action - Schindler asked about dividend plans"
["snippet_en"]=>
string(41) "The Swiss stock market rose on Wednesday."
["url"]=>
string(123) "https://www.cash.ch/news/top-news/borsen-ticker-schweizer-anleger-greifen-zu-schindler-nach-dividendenplanen-gefragt-683338"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f6846a31-b203-42a0-b3f4-3e2c101158cb"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2024-02-14"
["categories"]=>
array(8) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Going Public"
[2]=>
string(18) "General Investment"
[3]=>
string(12) "Stock Market"
[4]=>
string(14) "Cryptocurrency"
[5]=>
string(9) "Investors"
[6]=>
string(24) "Quarterly/Annual Figures"
[7]=>
string(11) "Acquisition"
}
}
[4]=>
array(7) {
["title_en"]=>
string(113) "Stock ticker: Index heavyweights slow down Swiss stock exchange - UBS on the decline - Swiss Re gained on Tuesday"
["snippet_en"]=>
string(72) "The Swiss stock market fell on Tuesday, bucking the global upward trend."
["url"]=>
string(144) "https://www.cash.ch/news/top-news/borsen-ticker-indexschwergewichte-bremsen-schweizer-borse-ubs-auf-talfahrt-swissre-am-dienstag-zugelegt-680820"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e64a5c8b-86c7-44f3-bf47-e6d94d435463"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2024-02-06"
["categories"]=>
array(6) {
[0]=>
string(15) "Market Movement"
[1]=>
string(12) "Going Public"
[2]=>
string(12) "Slash Prices"
[3]=>
string(12) "Stock Market"
[4]=>
string(21) "Shareholders Feedback"
[5]=>
string(31) "Financial Update/Profit Warning"
}
}
[5]=>
array(7) {
["title_en"]=>
string(108) "Stock market ticker: Swiss stock exchange without direction - Givaudan with a price gain of almost 8 percent"
["snippet_en"]=>
string(84) "The Swiss stock exchange closed just in the black on the second-to-last trading day."
["url"]=>
string(153) "https://www.cash.ch/news/top-news/borsen-ticker-smi-gibt-vor-ezb-zinsentscheid-nach-nestle-auf-2020-niveau-givaudan-im-aufwind-zehn-neue-kursziele-676997"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d8728946-c400-408f-bfc6-d910a24a9563"
["source"]=>
string(7) "cash.ch"
["publication_date"]=>
string(10) "2024-01-25"
["categories"]=>
array(14) {
[0]=>
string(20) "Contract negotiation"
[1]=>
string(15) "Market Movement"
[2]=>
string(24) "Stock Research & Ratings"
[3]=>
string(21) "Financial Performance"
[4]=>
string(19) "Economic Conditions"
[5]=>
string(12) "Going Public"
[6]=>
string(12) "Stock Market"
[7]=>
string(24) "Access and affordability"
[8]=>
string(11) "Sponsorship"
[9]=>
string(9) "Investors"
[10]=>
string(13) "Credit Rating"
[11]=>
string(24) "Quarterly/Annual Figures"
[12]=>
string(21) "Competitive Behaviour"
[13]=>
string(31) "Financial Update/Profit Warning"
}
}
[6]=>
array(7) {
["title_en"]=>
string(63) "Raiffeisen Stock Exchange daily: VAT suffers from profit-taking"
["snippet_en"]=>
string(175) "Raiffeisen Stock Exchange daily: It looks like a rather cautious start to the day today. Investors will continue to hold back ahead of US inflation data releases. Subscribe Si"
["url"]=>
string(88) "https://www.advisorworld.ch/raiffeisen-boerse-taeglich-vat-leidet-unter-gewinnmitnahmen/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fcddc530-339a-4c48-b997-4e3e92e6261e"
["source"]=>
string(15) "advisorworld.ch"
["publication_date"]=>
string(10) "2024-01-10"
["categories"]=>
array(4) {
[0]=>
string(9) "Investors"
[1]=>
string(10) "Relocation"
[2]=>
string(12) "Going Public"
[3]=>
string(12) "Stock Market"
}
}
[7]=>
array(7) {
["title_en"]=>
string(70) "Raiffeisen Stock Exchange daily: Nestlé and Roche had a slight impact"
["snippet_en"]=>
string(195) "Raiffeisen Stock Exchange daily: After yesterday's decision by the US Federal Reserve, the round continues today with the ECB, the Bank of England, the SNB and the Norges Bank. Subscribe to our k"
["url"]=>
string(89) "https://www.advisorworld.ch/raiffeisen-boerse-taeglich-nestle-und-roche-belasteten-etwas/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c30a79d5-d9fd-4655-81ad-529bc7476f35"
["source"]=>
string(15) "advisorworld.ch"
["publication_date"]=>
string(10) "2023-12-14"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(12) "Going Public"
[2]=>
string(46) "Management of Legal and Regulatory Environment"
}
}
[8]=>
array(7) {
["title_en"]=>
string(69) "Raiffeisen Stock Exchange daily: Pharmaceutical giants were in demand"
["snippet_en"]=>
string(168) "Raiffeisen Stock Exchange daily: Trading on the Swiss Stock Exchange is expected to start the day little changed. Subscribe to our free newsletter DER DAY | A quiet woc"
["url"]=>
string(84) "https://www.advisorworld.ch/raiffeisen-boerse-taeglich-pharmagiganten-waren-gefragt/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c896f0f0-7c89-4af1-b291-476effd7b487"
["source"]=>
string(15) "advisorworld.ch"
["publication_date"]=>
string(10) "2023-11-24"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(12) "Going Public"
[2]=>
string(15) "Market Movement"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(217)
}
[1]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(204)
}
[2]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(192)
}
[3]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(156)
}
[4]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(153)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(148)
}
[6]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(137)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(136)
}
[8]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(111)
}
[9]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(105)
}
[10]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(102)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(97)
}
[12]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(92)
}
[13]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(89)
}
[14]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(86)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(69)
}
[16]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(65)
}
[17]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(64)
}
[18]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(63)
}
[19]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(49)
}
[20]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(42)
}
[21]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(40)
}
[22]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(40)
}
[23]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(38)
}
[24]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(33)
}
[25]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(33)
}
[26]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(32)
}
[27]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(32)
}
[28]=>
array(2) {
["name"]=>
string(7) "Layoffs"
["count"]=>
int(32)
}
[29]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(32)
}
}
}
ef866-gb-roche-diagnostics-limited
ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
https://diagnostics.roche.com
Articles
3438 Articles
Category
Business Services, Not Elsewhere Classified
Description
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit https://careers.roche.com/global/en
Read our community guidelines here:
https://www.roche.com/some-guidelines.htm
#Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Raiffeisen Stock Exchange daily: It looks like a rather cautious start to the day today. Investors will continue to hold back ahead of US inflation data releases. Subscribe Si
Raiffeisen Stock Exchange daily: After yesterday's decision by the US Federal Reserve, the round continues today with the ECB, the Bank of England, the SNB and the Norges Bank. Subscribe to our k
Raiffeisen Stock Exchange daily: Trading on the Swiss Stock Exchange is expected to start the day little changed. Subscribe to our free newsletter DER DAY | A quiet woc
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.